CoChat

The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression

Maes, Michael, Yirmyia, Raz, Noraberg, Jens, Brene, Stefan, Hibbeln, Joe, Perini, Giulia, Kubera, Marta, Bob, Petr, Lerer, Bernard, Maj, Mario · 2009 · Metabolic Brain Disease

The DOI matches its Crossref record; 203 of the 203 references it cites were found in a registry or an index.

Abstract

Despite extensive research, the current theories on serotonergic dysfunctions and cortisol hypersecretion do not provide sufficient explanations for the nature of depression. Rational treatments aimed at causal factors of depression are not available yet. With the currently available antidepressant drugs, which mainly target serotonin, less than two thirds of depressed patients achieve remission. There is now evidence that inflammatory and neurodegenerative (I&ND) processes play an important role in depression and that enhanced neurodegeneration in depression may-at least partly-be caused by inflammatory processes. Multiple inflammatory-cytokines, oxygen radical damage, tryptophan catabolites-and neurodegenerative biomarkers have been established in patients with depression and these findings are corroborated by animal models of depression. A number of vulnerability factors may predispose towards depression by enhancing inflammatory reactions, e.g. lower peptidase activities (dipeptidyl-peptidase IV, DPP IV), lower omega-3 polyunsaturated levels and an increased gut permeability (leaky gut). The cytokine hypothesis considers that external, e.g. psychosocial stressors, and internal stressors, e.g. organic inflammatory disorders or conditions, such as the postpartum period, may trigger depression via inflammatory processes. Most if not all antidepressants have specific anti-inflammatory effects, while restoration of decreased neurogenesis, which may be induced by inflammatory processes, may be related to the therapeutic efficacy of antidepressant treatments. Future research to disentangle the complex etiology of depression calls for a powerful paradigm shift, i.e. by means of a high throughput-high quality screening, including functional genetics and genotyping microarrays; established and novel animal and ex vivo-in vitro models for depression, such as new transgenic mouse models and endophenotype-based animal models, specific cell lines, in vivo and ex vivo electroporation, and organotypic brain slice culture models. This screening will allow to: 1) discover new I&ND biomarkers, both at the level of gene expression and the phenotype; and elucidate the underlying molecular I&ND pathways causing depression; and 2) identify new therapeutic targets in the I&ND pathways; develop new anti-I&ND drugs for these targets; select existing anti-I&ND drugs or substances that could augment the efficacy of antidepressants; and predict therapeutic response by genetic I&ND profiles.

Overview

Integrity signals

Registry

Crossref · 10.1007/s11011-008-9118-1

Cites

203 of 203 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 203 references

Research works printed but not linked: 1

  1. Noraberg J, Jensen CV, Bonde C, Montero M, Nielsen JV, Jensen NA, Zimmer J (2007) Developmental expression of fluorescent proteins in organotypic hippocampal slice cultures from transgenic mice with example of excitotoxic neurodegeneration. ATLA. 35(1):61–70 Review

Cited by

See all 1,000

Metadata

Authors
Maes, M., Yirmyia, R., Noraberg, J., Brene, S., Hibbeln, J., Perini, G., Kubera, M., Bob, P., Lerer, B., & Maj, M.
Affiliations
  • University of Southern Denmark (DK)
  • National Institutes of Health (US)
  • University of Padua (IT)
  • Maj Institute of Pharmacology (PL)
  • Charles University (CZ)
  • Hebrew University of Jerusalem (IL)
Corresponding author
Maes, Michael
Venue
Metabolic Brain Disease
Published
2008-12-16
Volume
24
Issue
1
Pages
27-53
ISSN
  • 0885-7490 (ISSN-L)
  • 1573-7365
OpenAlex
W2089417699
Cited by
894
References
203
Citations by year
2026: 12 · 2025: 34 · 2024: 56 · 2023: 39 · 2022: 54 · 2021: 65 · 2020: 48 · 2019: 53 · 2018: 55 · 2017: 51 · 2016: 66 · 2015: 55 · 2014: 62 · 2013: 56 · 2012: 73
FWCI
12.81
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Metabolic Brain Disease (publishedVersion)
  • PubMed (publishedVersion)
  • Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
  • University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
  • Padua Research Archive (University of Padova) (submittedVersion)
Topics
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
Keywords
depression, neuroinflammation, neurodegeneration, cytokines, oxidative stress, tryptophan catabolites, neurodegeneration biomarkers, dipeptidyl peptidase IV, omega-3 polyunsaturated fatty acids, intestinal permeability, antidepressant efficacy, antidepressant drug development, antidepressant augmentation, animal models of depression, organotypic brain slice culture, etiology of depression
MeSH terms
Animals, Depressive Disorder, Disease Models, Animal, Encephalitis, Humans, Nerve Degeneration, Stress, Psychological, Tryptophan, Biomarkers, Causality, Cytokines, Oxidative Stress

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. https://app.cochat.ai/papers/10.1007/s11011-008-9118-1
The paper
Maes, M., Yirmyia, R., Noraberg, J., Brene, S., Hibbeln, J., Perini, G., Kubera, M., Bob, P., Lerer, B., & Maj, M. (2009). The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metabolic Brain Disease. https://doi.org/10.1007/s11011-008-9118-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.